Alaunos Therapeutics, Inc. (TCRT) insider trading

By person

29 insiders · 39 transactions

There is no salary here to measure against. Alaunos Therapeutics, Inc.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Vieser Jaime

Director

$1.00M (2)

$6.02K (2)

+$997.48K

1,372,642

54.03%

$2.75M

—

Cooper Laurence James Neil

President and CEO

$30.14K (1)

$826.61K (2)

−$796.48K

1,799,280

70.82%

$3.60M

+77.4%

Postma Robert W

Director

$617.25K (3)

—

+$617.25K

9,257,691

—

$18.52M

+11.8%

Lafond Kevin G

SVP, Treasurer & CAO

—

$215.08K (3)

−$215.08K

63,965

2.52%

$127.93K

+128.4%

Buck Jill

EVP, GM Gene Therapy

—

$214.08K (2)

−$214.08K

231,016

9.09%

$462.03K

+14.6%

De Groot Eleanor

EVP, Operations

—

$197.62K (3)

−$197.62K

237,106

9.33%

$474.21K

+19.0%

Huang James

Director

$171.00K (1)

—

+$171.00K

188,333

7.41%

$376.67K

—

Hadfield Robert

Chief Legal Officer and Sec.

—

$159.36K (2)

−$159.36K

176,819

6.96%

$353.64K

—

Weis Holger

CEO

$91.50K (1)

—

+$91.50K

44,683

1.76%

$89.37K

—

MAUNEY DAVID M MD

President

$19.98K (1)

$101.89K (1)

−$81.91K

275,778

10.86%

$551.56K

+407.0%

Hagen Heidi

Director

$41.84K (1)

—

+$41.84K

145,889

5.74%

$291.78K

+42,935%

Boyle Kevin S. Sr.

Chief Executive Officer

$14.00K (2)

$9.54K (1) scheduled

+$4.46K

798,236

31.42%

$1.60M

—

KIRK RANDAL J

Director

—

9,709,607

—

$19.42M

+0.2%

CANNON JAMES ANTHONY

Director

—

398,050

15.67%

$796.10K

+16.4%

Baffa Raffaele

Chief Medical Officer

—

280,645

11.05%

$561.29K

+40.3%

WEISER MICHAEL

Director

—

224,282

8.83%

$448.56K

+14.5%

BELBEL CAESAR J

COO, CLO, and Secretary

—

207,434

8.17%

$414.87K

+76.5%

LEBEL FRANCOIS

Executive Vice President R&D

—

200,566

7.89%

$401.13K

+208.6%

Fowler Wyche

Director

—

156,446

6.16%

$312.89K

+16.5%

Shukla Sath

EVP, Chief Financial Officer

—

80,500

3.17%

$161.00K

—

BRENNAN MURRAY

Director

—

72,620

2.86%

$145.24K

+61.6%

Ezickson Elan

Director

—

71,887

2.83%

$143.77K

—

Thistle Mary

Director

—

45,000

1.77%

$90.00K

—

Bowden Christopher

Director

—

44,167

1.74%

$88.33K

—

Pagan Douglas W.

Director

—

35,943

1.41%

$71.89K

—

Braunstein Scott

Director

—

31,780

1.25%

$63.56K

—

Jerman Michael Allen

Director

—

23,759

0.9352%

$47.52K

—

Groenewald Ferdinand

Vice President of Finance

—

10,775

0.4241%

$21.55K

—

BUCHI J KEVIN

Director

—

4,167

0.1640%

$8.33K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Vieser Jaime

31 Dec 2024

Director

Sell

818

$2.00

$1.64K

Vieser Jaime

31 Dec 2024

Director

Sell

2,182

$2.01

$4.39K

De Groot Eleanor

22 Dec 2021

EVP, Operations

Sell

20,132

$1.27

$25.57K

Hadfield Robert

8 Jan 2021

General Counsel and Secretary

Sell

26,500

$3.12

$82.68K

Lafond Kevin G

8 Jan 2021

SVP, Treasurer & CAO

Sell

18,020

$3.09

$55.68K

Buck Jill

8 Jan 2021

EVP, GM Gene Therapy

Sell

27,894

$3.12

$87.03K

Cooper Laurence James Neil

4 Jan 2021

President and CEO

Sell

105,693

$2.71

$286.43K

De Groot Eleanor

4 Jan 2021

EVP, GM Cell Therapy

Sell

21,620

$2.72

$58.81K

Buck Jill

2 Jan 2020

EVP, GM Gene Therapy

Sell

27,923

$4.55

$127.05K

De Groot Eleanor

2 Jan 2020

EVP, GM Cell Therapy

Sell

24,890

$4.55

$113.25K

Hadfield Robert

2 Jan 2020

General Counsel and Secretary

Sell

16,853

$4.55

$76.68K

Lafond Kevin G

2 Jan 2020

SVP, Treasurer & CAO

Sell

21,570

$4.55

$98.14K

MAUNEY DAVID M MD

2 Jan 2020

President

Sell

22,394

$4.55

$101.89K

Cooper Laurence James Neil

30 Dec 2019

Chief Executive Officer

Sell

110,694

$4.88

$540.19K

Show all 39 transactions →

Alaunos Therapeutics, Inc.

By person

Individual transactions

What was left out